BIP
FOLD

Brandes Investment Partners’s Amicus Therapeutics FOLD Stock Holding History

Brandes Investment Partners’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-36,700
Closed -$218K – 167
2014
Q3 		$218K Buy
+36,700
New +$192K ﹤0.01% 140
2014
Q2 		– Sell
-48,100
Closed -$100K – 166
2014
Q1 		$100K Buy
+48,100
New +$120K ﹤0.01% 161

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Brandes Investment Partners's FOLD Position: Q4 2014 in Review

Brandes Investment Partners sold out of Amicus Therapeutics (FOLD) in Q4 2014, closing a stake of 36,700 shares — an estimated $218K sold.

Brandes Investment Partners first reported a position in FOLD in Q1 2014 and held it in 2 quarters. The position peaked at $218K in Q3 2014. 109 funds tracked by Wall St. Rank hold FOLD as of Q4 2014.

  • Brandes Investment Partners reported no remaining Amicus Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Brandes Investment Partners sold 36,700 Amicus Therapeutics shares in Q4 2014, an estimated $218K.
  • Brandes Investment Partners first reported a position in Amicus Therapeutics in Q1 2014 and held it in 2 quarters.
  • Brandes Investment Partners's Amicus Therapeutics position peaked at $218K in Q3 2014.
  • 109 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2014.

Based on Brandes Investment Partners's 13F filing for Q4 2014, filed 10 Feb 2015.